Search Results 371-380 of 2431 for 2024embarking

1. Long-Term Safety of PF-00547659 in Ulcerative Colitis - Mayo Clinic

   Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to evaluate ...

2. A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) - Mayo Clinic

   About this study. This is a Phase 3, randomized, double-blind, placebo-controlled, multinational, and multicenter study to evaluate the efficacy of ...

3. Comparison of Acute Toxicities Between Patients Treated With Protons or Intensity Modulated Radiation Therapy After Surgery for the Treatment of Endometrial or Cervical Cancer - Mayo Clinic

   The purpose of this study is to evaluate whether proton radiation therapy (proton RT) reduces acute gastrointestinal toxicities at the end of treatment compared ...

4. Medical Research & Education - Mayo Clinic News Network

   Gene editing, gene therapy and tissue engineering are emerging regenerative biotherapies that are on the cusp of transforming medical care.

5. Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML - Mayo Clinic

   This study will compare the effects of Quizartinib versus placebo in combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase ...

6. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

   About this study. This is a multicenter, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of emricasan in improving ...

7. Simulation to Increase Multidisciplinary Teamwork and Decrease Health Care Worker Anxiety in High Risk Obstetrical Events - Mayo Clinic

   The purpose of this study is to determine if regulary occurring, multidisciplinary, tezam-based simulation of high risk obstetrical events is able to improve ...

8. A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread - Mayo Clinic

   The treatment for postmenopausal women diagnosed with hormone receptor positive (HR+) metastatic breast cancer (mBr) includes endocrine therapy However, de novo ...

9. PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer - Mayo Clinic

   About this study. A Phase II study to investigate the potential utility of PD 0332991 in the treatment of early stage ER+ Human epidermal growth factor ...

10. ISCHEMIA-Chronic Kidney Disease Trial - Mayo Clinic

    About this study. The purpose of the ISCHEMIA-CKD trial is to determine the best management strategy for patients with stable ischemic heart disease (SIHD), ...